Publicaciones (283) Publicaciones de FRANCISCO JAVIER ALVAREZ GONZALEZ

2023

  1. Economic Burden of the 2020 COVID-19 Hospitalizations in Spain

    JAMA network open, Vol. 6, Núm. 1, pp. e2250960

  2. Environmental factors are associated to hospital outcomes in COVID-19 patients during lockdown and post-lockdown in 2020: A nationwide study

    Environmental Research, Vol. 229

  3. Increase in driving after cocaine use in Spain: a cross-sectional dataset analysis for 2021

    Frontiers in Public Health, Vol. 11

  4. Medication economic burden of antidepressant non-adherence in Spain

    Frontiers in Pharmacology, Vol. 14

  5. Prevalence and cost of hospitalized patients with asymptomatic COVID-19 in 2020 in Spain

    Frontiers in Public Health, Vol. 11

  6. Trends in the Use of Driving-Impairing Medicines According to the DRUID Category: A Population-Based Registry Study with Reference to Driving in a Region of Spain between 2015 and 2019

    Pharmaceuticals, Vol. 16, Núm. 4

2022

  1. ABO Blood System and COVID-19 Susceptibility: Anti-A and Anti-B Antibodies Are the Key Points

    Frontiers in Medicine, Vol. 9

  2. Hospitalized COVID-19 Patients with Severe Acute Respiratory Syndrome: A Population-Based Registry Analysis to Assess Clinical Findings, Pharmacological Treatment and Survival

    Medicina (Lithuania), Vol. 58, Núm. 6

  3. Hyperoxemia in postsurgical sepsis/septic shock patients is associated with reduced mortality

    Critical Care, Vol. 26, Núm. 1

  4. Impact of the Economic Crisis on Endocarditis Mortality in Spain: A Nationwide Study

    International Journal of Health Services, Vol. 52, Núm. 3, pp. 383-391

  5. Non-Adherence to Antidepressant Treatment and Related Factors in a Region of Spain: A Population-Based Registry Study

    Pharmaceutics, Vol. 14, Núm. 12

2021

  1. A population-based registry analysis on hospitalized covid-19 patients with previous cardiovascular disease: Clinical profile, treatment, and predictors of death

    Journal of Cardiovascular Development and Disease, Vol. 8, Núm. 12

  2. Binding Potassium to Improve Treatment With Renin-Angiotensin-Aldosterone System Inhibitors: Results From Multiple One-Stage Pairwise and Network Meta-Analyses of Clinical Trials

    Frontiers in Medicine, Vol. 8

  3. Can the Cytokine Profile According to ABO Blood Groups Be Related to Worse Outcome in COVID-19 Patients? Yes, They Can

    Frontiers in Immunology, Vol. 12

  4. Clinical Profile, Pharmacological Treatment, and Predictors of Death Among Hospitalized COVID-19 Patients With Acute Kidney Injury: A Population-Based Registry Analysis

    Frontiers in Medicine, Vol. 8

  5. Evaluation of cytokines as robust diagnostic biomarkers for COVID-19 detection

    Journal of Personalized Medicine, Vol. 11, Núm. 7

  6. HGF, IL-1α, and IL-27 are robust biomarkers in early severity stratification of COVID-19 patients

    Journal of Clinical Medicine, Vol. 10, Núm. 9

  7. Positivity to cocaine and/or benzoylecgonine in confirmation analyses for on-road tests in spain

    International Journal of Environmental Research and Public Health, Vol. 18, Núm. 10

  8. Predictive modeling of poor outcome in severe covid-19: A single-center observational study based on clinical, cytokine and laboratory profiles

    Journal of Clinical Medicine, Vol. 10, Núm. 22

  9. The association of telomere length with substance use disorders: a systematic review and meta-analysis of observational studies

    Addiction, Vol. 116, Núm. 8, pp. 1954-1972